Trump cuts IVF drug deal with Merck in exchange for tariff exemption

EPA proposes amendments to weaken emission limits on ethylene oxide

The Environmental Protection Agency has proposed a series of amendments to weaken regulations on emissions of ethylene oxide, a gas that is primarily used to sterilize medical devices and equipment.

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Clinical, real-world data reaffirming the long-term effectiveness of Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) and Gardasil (Human Papillomavirus 4-valent Vaccine, Recombinant) against certain HPV-related cancers and diseases will be presented at the EUROGIN International Multidisciplinary HPV Congress 2026 in Vienna, Austria, March 18-21.

March 20, 2026

Vol.52 No.11

Cancer Policy

Trump administration announces “major crackdown” on healthcare fraud

HHS leadership has announced they will be pursuing steps to “crack down on fraud in Medicare and Medicaid.”

February 27, 2026

Vol.52 No.08

By Claire Marie Porter

Cancer Policy

White House launches TrumpRx website

TrumpRx, a direct-to-consumer drug purchasing platform, limited to self-pay patients, is live, as of Feb. 5.

Merck & Co. drug for treating NSCLC awarded FDA priority voucher

FDA has granted sacituzumab tirumotecan (sac-TMT), a trophoblast cell-surface antigen 2 directed antibody-drug conjugate, a priority voucher via the agency’s Commissioner’s National Priority Voucher (CNPV) Pilot Program.

January 09, 2026

Vol.52 No.1

By Claire Marie Porter

Cancer Policy

Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel

Harvey A. Risch, professor emeritus and senior research scientist at Yale School of Public Health, said he was named chair of the President’s Cancer Panel. Risch will succeed Elizabeth M. Jaffee, who was appointed by President Joe Biden in January 2023.

December 12, 2025

Vol.51 No.45

By Jacquelyn Cobb